Company & Sponsor Intelligence
Massachusetts General Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials12
Recruiting3
Completed8
Countries1
Therapeutic footprint
adhdalzheimersanxietyautismdepressionepilepsyunclassified
Indexed studies
NCT02536105PK/PD Pediatric ADHD Classroom Study
adhd · United StatesNA
adhd · United StatesNA
NCT01721330A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
adhd · United StatesPHASE4
adhd · United StatesPHASE4
NCT04271774Genome Environment Microbiome and Metabolome in Autism Study
autism · United StatesCOMPLETED
autism · United StatesCOMPLETED
NCT05189106Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial
alzheimers · United StatesPHASE1,PHASE2
alzheimers · United StatesPHASE1,PHASE2
NCT01246765National Pregnancy Registry for Psychiatric Medications
adhd · United StatesRECRUITING
adhd · United StatesRECRUITING
NCT01075672Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
adhd · United StatesNA
adhd · United StatesNA
NCT00181792Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta
adhd · United StatesCOMPLETED
adhd · United StatesCOMPLETED
NCT06974305PET/MRI/EEG Imaging Study in Epilepsy
epilepsy · United StatesRECRUITING
epilepsy · United StatesRECRUITING
NCT03757585Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
autism · United StatesPHASE4
autism · United StatesPHASE4
NCT01393301Integrated Treatment for Smoking Cessation & Anxiety in People With HIV
anxiety · United StatesNA
anxiety · United StatesNA
NCT05774665Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression
depression · United StatesPHASE2
depression · United StatesPHASE2
NCT04263519A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.
alzheimers · PHASE2
alzheimers · PHASE2
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →